Get access

Vascular Access Surveillance: Time to End the Controversy

Authors

  • Kevan R. Polkinghorne

    Corresponding author
    1. Department of Medicine, Monash University, Melbourne, Australia
    2. Department Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    • Department of Nephrology, Monash Medical Centre, Melbourne, Australia
    Search for more papers by this author

Address correspondence to: Kevan R. Polkinghorne, Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, Melbourne, Victoria 3168, Australia, Tel.: +61 3 9594 3522; +61 3 9594 3529, Fax: +61 3 9594 6530, or e-mail: kevan.polkinghorne@monash.edu

Abstract

The establishment and maintenance of permanent vascular access for hemodialysis patients are important clinical problems. Vascular access surveillance, currently mandated by the CMS, refers to the task of identifying and correcting an underlying vascular access stenosis to prolong vascular access patency and survival. While this premise makes intuitive sense, this article discusses the underlying evidence to support it, outlining disparate conclusions of clinical practice guidelines and a recent commentary by experts in vascular access.

Ancillary